Cocaine-Related Disorders
Information
- Disease name
- Cocaine-Related Disorders
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00218075 | Completed | Phase 2 | Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence | March 2000 | October 2007 |
| NCT00000188 | Completed | Phase 2 | Selegiline in Treatment of Cocaine Dependence - 2 | September 1994 | October 1995 |
| NCT00000189 | Completed | Phase 2 | Gepirone vs Placebo in Treatment of Cocaine Dependence - 3 | January 1990 | February 1991 |
| NCT00000190 | Completed | Phase 1 | Cocaine in Parotid Saliva, Blood and Urine - 4 | January 1991 | February 1992 |
| NCT00000191 | Completed | Phase 2 | Carbamazepine Treatment for Cocaine Dependence - 5 | January 1991 | February 1994 |
| NCT00000197 | Completed | Phase 2 | Propranolol for Treatment of Cocaine Addiction - 2 | January 1987 | January 2002 |
| NCT00000198 | Completed | Phase 1 | Piracetam for Treatment of Cocaine Addiction - 3 | October 1996 | October 1997 |
| NCT00142844 | Completed | Phase 2 | Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1 | September 1999 | January 2008 |
| NCT00149669 | Completed | N/A | Employment-based Reinforcement of Naltrexone Ingestion and Abstinence | December 2005 | December 2010 |
| NCT00158132 | Completed | Phase 2 | Effectiveness of Amantadine and Propranolol for Treating Cocaine Dependence - 2 | September 1999 | February 2006 |
| NCT00217997 | Completed | Impulsivity, Brain Function, and Substance Abuse Treatment in Cocaine Dependent Individuals | September 2005 | January 2013 | |
| NCT00218023 | Completed | Phase 2 | Medications for Stopping Cocaine Dependence and Preventing Relapse | March 2006 | April 2012 |
| NCT00218062 | Completed | Phase 2 | Effectiveness of Modafinil and D-amphetamine in Treating Cocaine Dependent Individuals | March 2006 | January 2012 |
| NCT00000187 | Completed | Phase 2 | Ritanserin in Treatment of Cocaine Dependence - 1 | July 1992 | |
| NCT00218166 | Completed | Phase 2 | Effectiveness of GABA Agonists in Reducing the Reinforcing Effects of Cocaine | August 2001 | May 2005 |
| NCT00218257 | Completed | N/A | Progesterone for the Treatment of Cocaine Dependence - 1 | July 2002 | June 30, 2008 |
| NCT00218348 | Completed | Phase 2 | Treatment of Cocaine Dependence: Comparison of Three Doses of Dextro-Amphetamine Sulfate and Placebo | September 2003 | November 2007 |
| NCT00218543 | Completed | Phase 2 | Atomoxetine for Treating Cocaine Abuse in Adults With Attention Deficit Hyperactivity Disorder (ADHD) | June 2004 | March 2007 |
| NCT00218608 | Completed | Phase 2 | Disulfiram for Treating Cocaine Dependence in Individuals Maintained on Methadone | April 2001 | January 2007 |
| NCT00223626 | Completed | Phase 2 | Topiramate to Reduce Cocaine Dependence | January 2007 | December 2010 |
| NCT00232336 | Completed | Phase 4 | Quetiapine for Cocaine Use and Cravings | October 2003 | January 2006 |
| NCT00249470 | Completed | N/A | The Therapeutic Workplace Initiation Study | April 2003 | October 2004 |
| NCT00249483 | Completed | Phase 2 | Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals | October 1999 | February 2005 |
| NCT00265265 | Completed | Phase 1 | Assessment of Potential Interactions Between Intravenous Cocaine and Atomoxetine - 1 | August 2005 | |
| NCT00276874 | Completed | Phase 1 | Aripiprazole to Reduce Cocaine Relapse | January 2006 | January 2012 |
| NCT00292110 | Completed | Phase 1 | Treatment of Heroin and Cocaine With Methadone Maintenance and Contingency Management | February 1, 2004 | August 9, 2013 |
| NCT00430690 | Completed | Acoustic Startle Reduction In Cocaine Dependence | September 2006 | July 19, 2011 | |
| NCT00733720 | Completed | Phase 1 | Buprenorphine Naltrexone-P1 A-Cocaine | August 2008 | January 2009 |
| NCT00780702 | Completed | Phase 1 | Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients | May 8, 2008 | April 16, 2013 |
| NCT00877435 | Completed | N/A | Prize Reinforcement Contingency Management for Cocaine Dependence: a 24-week Randomized Controlled Trial | September 2008 | October 2014 |
| NCT01526538 | Completed | Phase 2 | Improving Learning-based Treatment of Cocaine Dependence With Medication | September 2011 | March 2013 |
| NCT01723527 | Completed | Phase 1 | Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin | December 2012 | August 2014 |
| NCT01984177 | Completed | Effects of Corticorelin Administration on Dopamine Transmission, Craving, and Mood in Cocaine Dependence | June 2013 | June 2016 | |
| NCT02037126 | Completed | Phase 2 | Psilocybin-facilitated Treatment for Cocaine Use | May 2015 | May 2024 |
| NCT02563769 | Completed | Phase 1 | Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study | October 24, 2016 | May 25, 2018 |
| NCT02797990 | Completed | Conflict Between Maternal Autonomy and Child Health in Substance-use | May 2016 | September 2016 | |
| NCT02896712 | Completed | Phase 2 | Developing Adaptive Interventions for Cocaine Cessation and Relapse Prevention | November 18, 2016 | September 13, 2021 |
| NCT02915341 | Completed | Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network | May 1, 2016 | April 24, 2018 | |
| NCT03007394 | Completed | Phase 2 | Lorcaserin in the Treatment of Cocaine Use Disorder | December 19, 2017 | December 1, 2019 |
| NCT03556371 | Completed | Phase 2 | Evaluation of N-Acetylcysteine Efficacy to Reduce the Craving and to Prolong Abstinence Time of Coca Paste | April 9, 2018 | August 9, 2019 |
| NCT03606473 | Completed | Early Phase 1 | Brain Mechanisms in Young Adults | January 24, 2018 | August 31, 2020 |
| NCT03953612 | Completed | Early Phase 1 | The Role of Neuroactive Steroids in Stress, Drug Craving and Drug Use in Cocaine Use Disorders | March 12, 2019 | May 8, 2023 |
| NCT03986762 | Completed | Phase 1 | Open Label Pharmaco- Magnetic Resonance Spectrography (MRS) Study of Clavulanic Acid | March 12, 2019 | December 20, 2019 |
| NCT00000200 | Completed | Phase 2 | Cocaine Effects in Humans: Physiology and Behavior - 1 | January 1997 | January 1998 |
| NCT00000201 | Completed | Phase 2 | Pharmacological Modulation of Cocaine Effects - 1 | December 2001 | |
| NCT00000210 | Completed | Phase 2 | Treatment Efficacy for Drug Abuse and AIDS Prevention - 1 | September 1989 | February 1996 |
| NCT00000211 | Completed | Phase 2 | Treatment Efficacy for Drug Abuse and AIDS Prevention - 2 | September 1989 | February 1996 |
| NCT00000212 | Completed | Phase 2 | IV Cocaine Abuse: A Laboratory Model - 1 | July 1987 | July 1988 |
| NCT00000213 | Completed | Phase 2 | IV Cocaine Abuse: A Laboratory Model - 2 | April 1990 | April 1991 |
| NCT00000214 | Completed | Phase 2 | IV Cocaine Abuse: A Laboratory Model - 3 | January 1992 | January 1993 |
| NCT00000215 | Completed | Phase 2 | IV Cocaine Abuse: A Laboratory Model - 4 | December 2001 | |
| NCT00000216 | Completed | Phase 3 | Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1 | January 2005 | |
| NCT00000217 | Completed | Phase 2 | Pharmacotherapy and Intensive Treatment of Drug Abuse - 1 | September 1990 | |
| NCT00000218 | Completed | Phase 4 | Pharmacotherapy and Intensive Treatment - 2 | June 2005 | |
| NCT00000240 | Completed | Phase 2 | Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22 | April 1999 | |
| NCT00000242 | Completed | Phase 2 | Carbamazepine Treatment of Cocaine Dependence - 1 | October 1, 1992 | January 25, 1997 |
| NCT00000245 | Completed | Phase 2 | Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1 | May 1994 | December 2001 |
| NCT00000248 | Completed | Phase 3 | Dose Response Trial of Pergolide for Cocaine Dependence - 1 | February 1996 | |
| NCT00000266 | Completed | Phase 2 | Flupenthixol Treatment in Schizophrenic Cocaine Abusers - 1 | August 1994 | December 2001 |
| NCT00000267 | Completed | Phase 2 | Risperidone Treatment in Dually-Diagnosed Individuals - 2 | December 2001 | |
| NCT00000268 | Completed | N/A | Cocaine Abuse and Attention Deficit Disorder - 3 | May 1995 | November 1998 |
| NCT00000269 | Completed | Phase 2 | Pergolide Treatment for Substance Abusers - 4 | October 1995 | December 2001 |
| NCT00000271 | Completed | Phase 2 | New Approaches to Cocaine Abuse Medications (A) - 6 | January 1995 | October 2002 |
| NCT00000274 | Completed | Phase 2 | Flupenthixol and Haloperidol for Treating Cocaine Abuse Schizophrenics - 9 | March 1997 | May 1999 |
| NCT00000275 | Completed | Phase 2 | Cocaine Abuse and ADHD - 10 | November 1996 | March 1998 |
| NCT00000277 | Completed | Phase 2 | Mazindol for Cocaine Abuse - 2 | September 1994 | August 1999 |
| NCT00000278 | Completed | Phase 2 | Disulfiram for Cocaine-Alcohol Abuse - 3 | September 1994 | August 1999 |
| NCT00000280 | Completed | Phase 1 | Glutaminergic Agents for Cocaine Abuse - 5 | September 1994 | August 1999 |
| NCT00000281 | Completed | Phase 2 | Pharmacotherapy for Schizophrenic Drug Users - 6 | September 1994 | August 1999 |
| NCT00000282 | Completed | Phase 2 | Pemoline for Cocaine Abuse - 7 | September 1994 | August 1999 |
| NCT00000285 | Completed | Phase 1 | Effects of Phenytoin on Cocaine Use in Humans - 2 | May 1996 | December 2001 |
| NCT00000286 | Completed | Phase 2 | Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3 | December 1996 | December 2001 |
| NCT00000287 | Completed | Relapse Patterns in Female Cocaine Users - 4 | February 1995 | December 2001 | |
| NCT00000290 | Completed | Phase 1 | Stress Hormones and Human Cocaine Use - 7 | May 1997 | December 2001 |
| NCT00000291 | Completed | Phase 2 | Effects of Labetalol on Human Cocaine Use - 8 | October 1997 | December 2001 |
| NCT00000292 | Completed | Phase 1 | Acute Withdrawal From Smoked Cocaine - 9 | April 1996 | December 2001 |
| NCT00000293 | Completed | Phase 3 | Effect of Nefazodone on Relapse in Females With Cocaine Abuse - 10 | January 1999 | December 2001 |
| NCT00000294 | Completed | Phase 2 | Effects of Carvedilol on Cocaine Use in Humans - 11 | September 1998 | December 2001 |
| NCT00000301 | Completed | Phase 2 | Rapid Evaluation of Amantadine for Treatment of Cocaine Abuse/Dependence - 4 | March 1996 | |
| NCT00000303 | Completed | Phase 2 | Rapid Evaluation of Baclofen for Treatment of Cocaine Abuse/Dependence - 6 | October 1997 | |
| NCT00000304 | Completed | Phase 2 | Dextroamphetamine as an Adjunct in Cocaine Treatment - 1 | August 1997 | August 2001 |
| NCT00000306 | Completed | Phase 2 | Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3 | September 1994 | September 2001 |
| NCT00000307 | Completed | Phase 2 | Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4 | April 2003 | April 2007 |
| NCT00000308 | Completed | Phase 2 | Dextroamphetamine-Cocaine Behavioral Intervention - 5 | September 1995 | September 2000 |
| NCT00000311 | Completed | Phase 3 | Combining Behavioral Treatment With Agonist Maintenance - 1 | February 1995 | February 1999 |
| NCT00000312 | Completed | Phase 1 | Alterations in Serotonergic Functions in Cocaine Addicts - 1 | ||
| NCT00000314 | Completed | Phase 2 | M-CPP and Fenfluramine in Cocaine Addicts - 3 | September 1994 | August 1999 |
| NCT00000315 | Completed | Phase 1 | Human Dopamine Transported Imaging in Cocaine Abuse: 1 - 1 | November 1996 | December 2001 |
| NCT00000316 | Completed | Phase 1 | Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2 | August 1996 | December 2001 |
| NCT00000317 | Completed | Phase 2 | Early Phase II Trials for Cocaine Medication Development - 1 | August 1996 | July 1999 |
| NCT00000323 | Completed | Therapeutic Potential of Kappa-Opioids Against Cocaine - 1 | July 1996 | December 1998 | |
| NCT00000324 | Completed | Phase 2 | Tryptophan and Behavior Therapy for Cocaine Abuse - 1 | March 1997 | April 2001 |
| NCT00000325 | Completed | Phase 1 | Psychostimulant Abuse - Novel Treatment Approaches - 1 | December 2001 | |
| NCT00000332 | Completed | Phase 2 | High Dose Nimodipine Treatment Adjunct - 1 | May 1998 | April 2000 |
| NCT00000333 | Completed | Phase 2 | Evaluation of Benztropine for Cocaine Craving - 2 | May 2001 | April 2003 |
| NCT00000336 | Completed | Phase 2 | Selegiline in Outpatient Treatment for Cocaine Dependence - 1 | January 1995 | March 1996 |
| NCT00000337 | Completed | Phase 1 | Infusion Laboratory: Protocol 1 - Selegeline - 2 | November 1994 | |
| NCT00000342 | Completed | Phase 2 | Risperidone for the Treatment of Cocaine Dependence - 7 | July 1996 | September 1997 |
| NCT00000347 | Completed | Phase 2 | Risperidone for Treatment of Cocaine Dependence in Outpatients - 12 | July 1997 | September 1998 |
| NCT00015054 | Completed | Phase 2 | Methylphendidate Treatment of Cocaine Dependent Patients With Attention Deficit Hyperactivity Disorder - 3 | September 1998 | November 1999 |
| NCT00015067 | Completed | Phase 1 | Cocaine-Methylphendidate Interaction Study - 4 | December 1997 | |
| NCT00015080 | Completed | Phase 2 | Naltrexone in Treatment of Cocaine Dependence - 5 | May 1995 | July 1996 |
| NCT00015106 | Completed | Phase 2 | Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7 | November 1997 | February 1999 |
| NCT00015132 | Completed | Phase 2 | Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9 | March 1999 | November 2000 |
| NCT00015210 | Completed | Phase 2 | Nefazodone in the Treatment of Cocaine Dependence and Depression - 4 | February 1997 | |
| NCT00015223 | Completed | Phase 2 | Methylphenidate in the Treatment of Cocaine Dependent Patients With Adult Attention Deficit Hyperactivity Disorder - 5 | June 1997 | August 1999 |
| NCT00015236 | Completed | Phase 4 | Modeling Impaired Judgement in Cocaine Abusers - 6 | March 1997 | |
| NCT00015249 | Completed | Phase 1 | Prepulse Inhibition of Startle in Cocaine Dependence - 7 | February 1997 | May 1998 |
| NCT00015275 | Completed | Phase 4 | Pathophysiological Subtyping of Abnormalities in Cocaine Dependence - 9 | ||
| NCT00015301 | Completed | Phase 4 | Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11 | December 2003 | August 2005 |
| NCT00032929 | Completed | Phase 3 | Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1 | March 2001 | |
| NCT00033033 | Completed | Phase 2 | Reserpine for the Treatment of Cocaine Dependence - 1 | July 2001 | May 2003 |
| NCT00033085 | Completed | Phase 2 | Ondansetron for the Treatment of Cocaine Dependence - 1 | May 2001 | December 2002 |
| NCT00033111 | Completed | Phase 2 | A Study of Cabergoline for the Treatment of Cocaine Dependence - 1 | June 2001 | April 2004 |
| NCT00067535 | Completed | Phase 1 | Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1 | June 2003 | June 2005 |
| NCT00082485 | Completed | Phase 2 | Baclofen for the Treatment of Cocaine Dependence - 1 | June 2004 | |
| NCT00086255 | Completed | Phase 2 | Tiagabine for the Treatment of Cocaine Dependence - 1 | October 2002 | June 2004 |
| NCT00100100 | Completed | Phase 2 | Modafinil for the Treatment of Cocaine Dependence - 1 | October 2004 | December 2006 |
| NCT00124696 | Completed | Phase 1 | Cocaethylene as a Treatment for Cocaine Dependence - 1 | December 2002 | March 2005 |
| NCT00129285 | Completed | Phase 2 | Modafinil Treatment for Cocaine-Dependent Individuals | July 2004 | April 2008 |
| NCT00129298 | Completed | Phase 2 | Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1 | December 2004 | April 2007 |
| NCT00134901 | Completed | Phase 2 | Effectiveness of Memantine in Treating Cocaine-Dependent Individuals - 2 | March 2003 | May 2007 |
| NCT00136734 | Completed | Phase 1 | Methylphenidate Treatment for Cocaine Abuse and ADHD - 1 | April 1998 | March 2004 |
| NCT00136825 | Completed | Phase 1 | Effectiveness of N-acetylcysteine in Treating Cocaine Dependent Individuals - 1 | March 2003 | September 2005 |
| NCT00142779 | Completed | N/A | Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts | April 2001 | March 2006 |
| NCT00142818 | Completed | Phase 2 | Modafinil and Naltrexone to Reduce Cocaine and Alcohol Dependence | February 2006 | August 2013 |
| NCT04155632 | Recruiting | Phase 2 | Neurocircuit Strategy to Decrease Cocaine Cue Reactivity | December 18, 2020 | December 31, 2024 |
| NCT00396734 | Suspended | N/A | The Effects of Pharmacotherapy on Brain Mechanisms Underlying Cocaine Dependence. | April 2007 | April 2011 |
| NCT00000310 | Terminated | Phase 2 | Serotonin/Dopamine Antagonism of Cocaine Effect: 2 - 2 | January 1996 | March 1996 |
| NCT00142883 | Terminated | N/A | The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3 | September 2004 | September 2006 |
| NCT00218049 | Terminated | Phase 1 | Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals | December 2004 | July 2005 |
| NCT00514202 | Terminated | Phase 2 | Pilot Study Examining Effect for Dextroamphetamine to Treat Cocaine Dependence Plus Attention-deficit Hyperactivity Disorder (ADHD) | August 2007 | October 2008 |
| NCT00000276 | Terminated | Phase 1 | Dopamine Reuptake Inhibitors of Cocaine Abuse - 1 | September 1994 | August 1999 |
| NCT00000313 | Terminated | Phase 1 | Predictive Values of Serotonergic Alterations for Outcome - 2 | ||
| NCT03143543 | Terminated | Phase 1 | Phase I Functional Magnetic Resonance Imaging (fMRI) Pharmacodynamic Studies of Compounds for Opioid Use Disorder and Cocaine Use Disorder | July 2015 | December 6, 2019 |
| NCT00000305 | Terminated | Phase 1 | Amphetamine Cocaine Interaction Study - 2 | ||
| NCT00000309 | Terminated | Phase 2 | Serotonin/Dopamine Antagonism of Cocaine Effect: 1 - 1 | August 1994 | January 2000 |
| NCT00033059 | Unknown status | Phase 1 | Assessment of Potential Interactions Between Cocaine and Tolcapone - 1 | July 2001 | March 2002 |
| NCT03333460 | Unknown status | N/A | Transcranial Magnetic Stimulation for Cocaine Addiction | October 1, 2017 | December 1, 2020 |
| NCT00033098 | Unknown status | Phase 1 | Cocaine-Metyrapone Interaction Study - 1 | November 2001 | May 2002 |
| NCT00040066 | Unknown status | Phase 1 | Development of Human Laboratory Study Model of Cocaine Relapse Prevention. - 1 | May 2002 | August 2003 |
| NCT00051896 | Unknown status | Phase 1 | Assessment of the Potential Interactions Between Cocaine and GBR 12909 - 1 | August 2002 | |
| NCT00087750 | Unknown status | Phase 1 | Interaction Between Cocaine and Quetiapine - 1 | October 2003 | |
| NCT00089687 | Unknown status | Phase 1 | GBR 12909 Study in Cocaine Experienced African American Volunteers - 1 | April 2004 | May 2005 |
| NCT00094289 | Unknown status | Phase 1 | Interactions Between Cocaine and Ethanol and Disulfiram - 1 | August 2004 | July 2005 |
| NCT00094315 | Unknown status | Phase 1 | Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1 | September 2004 | July 2005 |
| NCT00100113 | Unknown status | Phase 1 | Assessment of Potential Interactions Between GBR 12909 and Cocaine - 1 | June 2004 | June 2005 |
| NCT03902405 | Unknown status | N/A | Computerized Exercise to Alter Stimulant Approach Responses | June 11, 2018 | March 31, 2022 |
| NCT00249691 | Unknown status | Phase 3 | Effectiveness of Topiramate in Treating Cocaine Dependent Individuals - 1 | October 2005 | October 2012 |
| NCT02986438 | Unknown status | N/A | Treatment With Transcranial Magnetic Stimulation for Cocaine Addiction: Clinical Response and Functional Connectivity. | May 1, 2017 | December 31, 2020 |
| NCT04280900 | Unknown status | N/A | Benefits of Therapy With Virtual Reality Exposure in the Treatment of Cocaine Use Disorders | June 1, 2020 | December 31, 2021 |
| NCT00032916 | Unknown status | Phase 1 | Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1 | June 2001 | December 2002 |
| NCT00033046 | Unknown status | Phase 1 | Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1 | June 2001 | April 2002 |
| NCT04306354 | Unknown status | Phase 1/Phase 2 | Use of Intranasal Oxytocin During Detoxification of Crack Cocaine | September 15, 2018 | May 31, 2020 |
| NCT00000348 | Unknown status | Phase 1 | Infusion Laboratory: Protocol 4 (Dihydrexidine) - 13 | ||
| NCT00000349 | Unknown status | Phase 1 | Infusion Laboratory: Protocol 5 (Flupenthixol) - 14 | ||
| NCT00000338 | Unknown status | Phase 1 | Infusion Laboratory: Protocol 2 (Lisuride) - 3 | March 1996 | |
| NCT00000339 | Unknown status | Phase 1 | Infusion Laboratory: Protocol 3 (Risperidone) - 4 | June 1996 | |
| NCT02773212 | Unknown status | Phase 2 | Targeting Anhedonia in Cocaine Use Disorder | February 1, 2017 | April 2022 |
| NCT00000270 | Withdrawn | Phase 4 | Brain Imaging: Cocaine Effects & Medication Development - 5 | December 30, 1995 | December 30, 1995 |
| NCT00000340 | Withdrawn | Phase 2 | Pemoline in the Treatment of Stimulant Dependence - 5 | June 1996 | |
| NCT00000199 | Withdrawn | Phase 1 | Piracetam for Treatment of Cocaine Addiction, Phase II - 4 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D019970